ANDA 215101

RUBICON

FDA Drug Application

Application #215101

Application Sponsors

ANDA 215101

RUBICON

Marketing Status

• Prescription: 001
• Prescription: 002

Application Products

001	TABLET;ORAL	125MG	0	ACETAZOLAMIDE	ACETAZOLAMIDE
002	TABLET;ORAL	250MG	0	ACETAZOLAMIDE	ACETAZOLAMIDE

FDA Submissions

UNKNOWN;

ORIG

1

AP

2021-08-19

STANDARD

Submissions Property Types

ORIG

1

Null

15

TE Codes

001	Prescription	AB
002	Prescription	AB

CDER Filings

RUBICON

cder:Array
(
    [0] => Array
        (
            [ApplNo] => 215101
            [companyName] => RUBICON
            [docInserts] => ["",""]
            [products] => [{"drugName":"ACETAZOLAMIDE","activeIngredients":"ACETAZOLAMIDE","strength":"125MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"ACETAZOLAMIDE","activeIngredients":"ACETAZOLAMIDE","strength":"250MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"08\/19\/2021","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2021-08-19
        )

)